Phase 2 study of ibrutinib in classic and variant hairy cell leukemia
伊布替尼治疗经典型和变异型毛细胞白血病的 II 期研究
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2020009688
Rogers, Kerry A; Andritsos, Leslie A; Wei, Lai; McLaughlin, Eric M; Ruppert, Amy S; Anghelina, Mirela; Blachly, James S; Call, Timothy; Chihara, Dai; Dauki, Anees; Guo, Ling; Ivy, S Percy; James, Lacey R; Jones, Daniel; Kreitman, Robert J; Lozanski, Gerard; Lucas, David M; Ngankeu, Apollinaire; Phelps, Mitch; Ravandi, Farhad; Schiffer, Charles A; Carson, William E; Jones, Jeffrey A; Grever, Michael R